NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 193 filers reported holding NEKTAR THERAPEUTICS in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $357 | +3.5% | 600 | 0.0% | 0.00% | – |
| Q2 2023 | $345 | -18.1% | 600 | 0.0% | 0.00% | – |
| Q1 2023 | $421 | -69.0% | 600 | 0.0% | 0.00% | – |
| Q4 2022 | $1,356 | -99.9% | 600 | 0.0% | 0.00% | – |
| Q3 2022 | $1,920,000 | -15.8% | 600 | 0.0% | 0.00% | – |
| Q2 2022 | $2,280,000 | -29.5% | 600 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $3,234,000 | -60.1% | 600 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $8,106,000 | -24.8% | 600 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $10,776,000 | +4.7% | 600 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $10,296,000 | -14.2% | 600 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $12,000,000 | +17.6% | 600 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $10,200,000 | -26.6% | 600 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $13,896,000 | +29.7% | 600 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $10,710,000 | -17.3% | 600 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $12,951,000 | +18.5% | 600 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $10,929,000 | -48.8% | 600 | 0.0% | 0.00% | -57.1% |
| Q2 2019 | $21,348,000 | -50.5% | 600 | -53.3% | 0.01% | -56.2% |
| Q1 2019 | $43,142,000 | +2.2% | 1,284 | 0.0% | 0.02% | -5.9% |
| Q4 2018 | $42,205,000 | -88.3% | 1,284 | -80.8% | 0.02% | -85.8% |
| Q3 2018 | $359,896,000 | +1140.3% | 6,692 | +1015.3% | 0.12% | +1100.0% |
| Q2 2018 | $29,016,000 | -54.5% | 600 | 0.0% | 0.01% | -50.0% |
| Q1 2018 | $63,756,000 | – | 600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |